A synthetic peptide for use as a blocking control in assays to test for specificity of FANCL antibody, Alternative Names: FANCL control peptide, FANCL antibody Blocking Peptide, Anti-FANCL Blocking Peptide, Fanconi Anemia Complementation Group L Blocking Peptide, FAAP43 Blocking Peptide, FLJ10335 Blocking Peptide, PHF9 Blocking Peptide, POG Blocking Peptide
Optimal conditions should be determined by the investigator
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Conseil sur la manipulation
Avoid repeated freeze/thaw cycles.
Stock
-20 °C
Stockage commentaire
Store at -20 °C long term.
Antigène
FANCL
(Fanconi Anemia, Complementation Group L (FANCL))
Sujet
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ, FANCL, FANCM and FANCN. The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair.